The Clinical Usage of a Free Gingival Graft Combined With Frenotomy in Patients With High Frenal Attachment

October 21, 2023 updated by: Mohammed Saleh Saleh Saleh, Cairo University

The Clinical Usage of a Free Gingival Graft Combined With Frenotomy in Patients With High Frenal Attachment: A Clinical Case Series

In patients with high frenal attachment will placement of free gingival graft combined with frenotomy result in gain of width of keratinized gingiva, decrease relapse, improve mucosal healing and have acceptable postoperative pain?

Study Overview

Detailed Description

In patients with high frenal attachment will placement of free gingival graft combined with frenotomy result in gain of width of keratinized gingiva, decrease relapse, improve mucosal healing and have acceptable postoperative pain?

To the best of our knowledge there aren't any studies discussing the use of free gingival graft in combination with frenotomy procedure to decrease relapse & morbidity of the condition; thus the objective of this case series study is to evaluate the effectiveness of using free gingival graft in combination with frenotomy procedure on increasing the width of keratinized tissue & decreasing relapse, postoperative pain and scar formation.

Inclusion criteria:

Ages 18-40 years old Systemically healthy Gingival and plaque index <10 Good oral hygiene Highly attached mandibular labial frenum. Narrow sulcus depth Thin gingival phenotype

Exclusion criteria:

Smokers Poor oral hygiene Patient with a physical disability that hinders the upkeep of good oral hygiene measures.

Taking any medications that could affect healing Any systemic diseases that delay wound healing. Deep sulcus Thick gingival phenotype Pervious frenal procedures Pregnant or lactating females Pervious periodontal surgery within the last 6 months before the start of the trial

Interventions

Preoperative measures:

  1. All subjects will pass through phase I therapy (Supragingival scaling, subgingival debridement and oral hygiene instructions) before any surgical procedures.
  2. After 4 weeks, all subjects will be examined to determine patient compliance with oral hygiene procedures (tooth brushing twice daily and chlorhexidine HCL 1.25% mouthwash twice daily).
  3. Eligible & complied patients will be enrolled in the study

Intervention - Surgical Phase (T0):

  1. The same operator (M S) will perform all procedures.
  2. After following complete aseptic precautions, surgical technique will be performed. Local infiltration will be done using local anaesthetic solution 4% articaine with 1/200 000 adrenaline solution.
  3. A horizontal incision will be placed at mucogingival junction using 15c blade with respect to teeth 42,41,31,32, which is then followed by supraperiosteal dissection or frenal relocation of the mandibular labial frenum up to the desired level using periosteal elevator.
  4. Undermining the edges of the frenum using periosteal elevator separating the epithelium from the underlining lip mucosa.
  5. The mucosa is sutured in the periosteum by using simple interrupted suture at the desired new level of the frenum.
  6. Gauze moistened with saline is to be placed over the recipient bed until graft placement.
  7. A free gingival autograft will be harvested from the palate using 15c blade and tissue forceps.
  8. Stabilization of the free gingival autograft in place using a 6-0 resorbable Vicryl suture using combination of interrupted and sling sutures.

Post-operative care:

  1. Patients abstained from tooth brushing for 2 days post-operatively.
  2. Using 0.2% cholohexidine mouthwash twice daily for 14 days to be started on the 2nd day of surgery.
  3. Ibuprofen 600 mg 1 tablet PRN.
  4. Patients will be instructed to:

    1. Follow the instructions completely.
    2. Keep up a strict follow-up schedule.
    3. Brush their teeth twice a day, with a soft brush, and avoid brushing the surgical area (to be started 2 days post-surgery).
    4. Not to touch the surgical area, with the tongue or fingers.
    5. Do not wear any kind of dental appliances, on or around the surgical site.
    6. Not to eat or bite on the anterior teeth during the healing period.

Follow-up (T1, T2,T3, T4):

T1 1. Patients recalled after 5 days for measurement of mucosal healing using IPR (Inflammatory, Proliferativ, & Remodeling) Wound Healing Scale (Hamzani & Chaushu, 2018).

T2

  1. Patients recalled after 14 days for suture removal.
  2. Measurement of pain score using Numerical Rating scale (NRS) measurement. (Williamson & Hoggart, 2005).
  3. Measurement of mucosal healing using IPR (Inflammatory, Proliferativ, & Remodeling) Wound Healing Scale (Hamzani & Chaushu, 2018).

T3

  1. Patients recalled after 2 months.
  2. Measurement of mucosal healing using IPR (Inflammatory, Proliferativ, & Remodeling) Wound Healing Scale (Hamzani & Chaushu, 2018).

T4

1. Patients recalled after 3 months for the evaluation of frenum relapse using periodontal probe (Sarmadi et al., 2021).

Study Type

Interventional

Enrollment (Estimated)

12

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Ages 18-40 years old
  • Systemically healthy
  • Gingival and plaque index <10
  • Good oral hygiene
  • Highly attached mandibular labial frenum.
  • Narrow sulcus depth
  • Thin gingival phenotype

Exclusion Criteria:

  • Smokers
  • Poor oral hygiene
  • Patient with a physical disability that hinders the upkeep of good oral hygiene measures.
  • Taking any medications that could affect healing
  • Any systemic diseases that delay wound healing.
  • Deep sulcus
  • Thick gingival phenotype
  • Pervious frenal procedures
  • Pregnant or lactating females
  • Pervious periodontal surgery within the last 6 months before the start of the trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Combining Free Gingival Graft with frenotomy procedure
evaluate the usage of free gingival graft combined with frenotomy in order to measure the gain in the width of keratinized gingiva, relapse, mucosal healing and postoperative pain.
The aim of the study is to evaluate the usage of free gingival graft combined with frenotomy in order to measure the gain in the width of keratinized gingiva, relapse, mucosal healing and postoperative pain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Width of keratinized tissue
Time Frame: T1: 5days post-surgery, T2:14 days post-surgery, T3: 2months post-surgery & T4: 3months post-surgery.
It will be measured using periodontal probe at T1, T2, T3 and T4
T1: 5days post-surgery, T2:14 days post-surgery, T3: 2months post-surgery & T4: 3months post-surgery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mucosal healing
Time Frame: T1: 5days post-surgery, T2:14 days post-surgery, T3: 2months post-surgery
it will be measured using IPR (Inflammatory Proliferative Remodeling) Wound Healing Scale at T1, T2 and T3.
T1: 5days post-surgery, T2:14 days post-surgery, T3: 2months post-surgery
Post-operative pain
Time Frame: T2:14 days post-surgery.
it will be measured using Numerical Rating scale (NRS) at T2
T2:14 days post-surgery.
Relapse
Time Frame: T4: 3months post-surgery.
it will be measured using periodontal probe at T4
T4: 3months post-surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Manal Hosny, Professor, Cairo University
  • Study Chair: Nada Zazou, Ass Lecturer, MSA University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2023

Primary Completion (Estimated)

March 1, 2024

Study Completion (Estimated)

August 1, 2024

Study Registration Dates

First Submitted

October 21, 2023

First Submitted That Met QC Criteria

October 21, 2023

First Posted (Actual)

October 26, 2023

Study Record Updates

Last Update Posted (Actual)

October 26, 2023

Last Update Submitted That Met QC Criteria

October 21, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • MohSaleh123

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on High Frenum Attachment

Clinical Trials on Combining free gingival graft with frenotomy procedure

3
Subscribe